advertisement

Topcon

Martin KR 33

Showing records 1 to 25 | Display all abstracts from Martin KR

60085 Glial cell interactions and glaucoma
Chong RS
Current Opinions in Ophthalmology 2015; 26: 73-77
60797 Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study
Nesaratnam N
BMC Ophthalmology 2015; 15: 17
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Jackson DJ
BMJ open 2014; 4: e005965
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
White AJ
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60085 Glial cell interactions and glaucoma
Martin KR
Current Opinions in Ophthalmology 2015; 26: 73-77
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Razai MS
BMJ open 2014; 4: e005965
60797 Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study
Sarkies N
BMC Ophthalmology 2015; 15: 17
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP
Lancet 2015; 385: 1295-1304
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Heller JP; Leung J
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Bunce C
Lancet 2015; 385: 1295-1304
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Falama R
BMJ open 2014; 4: e005965
60797 Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study
Martin KR; Shahid H
BMC Ophthalmology 2015; 15: 17
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G
Lancet 2015; 385: 1295-1304
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Mongwa M
BMJ open 2014; 4: e005965
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Tassoni A
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Mutapanduwa M
BMJ open 2014; 4: e005965
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
Martin KR
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Amalfitano F; Anand N
Lancet 2015; 385: 1295-1304
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Baemisi C; Josiah E
BMJ open 2014; 4: e005965
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Azuara-Blanco A; Bourne RR
Lancet 2015; 385: 1295-1304
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Nkomazana O
BMJ open 2014; 4: e005965
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Broadway DC
Lancet 2015; 385: 1295-1304
60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Lehasa A; Brealey E
BMJ open 2014; 4: e005965
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Cunliffe IA
Lancet 2015; 385: 1295-1304

Issue 16-4

Change Issue


advertisement

Oculus